Go Pro
LON:CYBG

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Share Price, News & Analysis

GBX 14.34 0.00 (0.00%)
As of 08/28/2026 11:38 AM Eastern

About VanEck Bionic Engineering UCITS ETF A Acc Stock (LON:CYBG)

Advanced

Key Stats

Today's Range
14.20
14.34
50-Day Range
13.24
14.76
52-Week Range
12.40
16.50
Volume
215 shs
Average Volume
996 shs
Market Capitalization
£205.71 million
P/E Ratio
N/A
Dividend Yield
2.25%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Providing investors access to opportunities that will strengthen their portfolios is VanEck’s guiding principle. Through forward-looking, intelligently designed active and ETF solutions, we offer value-added exposures to emerging industries, asset classes and markets as well as differentiated approaches to traditional strategies. We think beyond the financial markets to identify the trends—including economic, technological, political and social—that we believe will fuel investable opportunities. VanEck was one of the first U.S. asset managers to offer investors access to international markets and recognized early the transformative potential of gold investing, emerging markets and ETFs. Today, our firm’s capabilities range from core investment opportunities to more specialized exposures to enhance portfolio diversification.

Receive CYBG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Bionic Engineering UCITS ETF A Acc and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CYBG Stock News Headlines

Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
VanEck Bionic Engineering UCITS ETF (CYBO.L)
Vaneck Sustainable World Ew Ucits Etf Share Chat
VanEck Global Mining UCITS A (GIGB)
See More Headlines

CYBG Stock Analysis - Frequently Asked Questions

VanEck Bionic Engineering UCITS ETF A Acc's stock was trading at GBX 15.67 at the beginning of 2026. Since then, CYBG shares have decreased by 8.5% and is now trading at GBX 14.34.

Shares of CYBG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Bionic Engineering UCITS ETF A Acc investors own include Virgin Money UK (VMUK), G-III Apparel Group (GIII), Alphabet (GOOG), Ionis Pharmaceuticals (IONS), Svenska Handelsbanken Ab Publ (SVNLY) and Western Union (WU).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
LON:CYBG
CIK
N/A
Fax
N/A
Employees
5,762
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
0.00
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
£1.24 billion
Price / Sales
0.17
Cash Flow
GBX 107.26 per share
Price / Cash Flow
0.13
Book Value
GBX 355.10 per share
Price / Book
0.04

Miscellaneous

Outstanding Shares
1,434,489,984
Free Float
N/A
Market Cap
£205.71 million
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (LON:CYBG) was last updated on 8/31/2026 by MarketBeat.com Staff.
From Our Partners